Role of stem cell mobilization in the treatment of ischemic diseases

다국어 초록 (Multilingual Abstract)

Stem cell mobilization plays important roles in the treatment of severe ischemic diseases, including myocardial infarction, limb ischemia, ischemic stroke, and acute kidney injury. Stem cell mobilization refers to the egress of heterogeneous stem cells residing in the bone marrow into the peripheral blood. In the clinic, granulocyte colony-stimulating factor (G-CSF) is the drug most commonly used to induce stem cell mobilization. Plerixafor, a direct antagonist of CXCR4, is also frequently used alone or in combination with G-CSF to mobilize stem cells. The molecular mechanisms by which G-CSF induces stem cell mobilization are well characterized. Briefly, G-CSF activates neutrophils in the bone marrow, which then release proteolytic enzymes, such as neutrophil elastase, cathepsin G, and matrix metalloproteinase 9, which cleave a variety of molecules responsible for stem cell retention in the bone marrow, including CXCL12, VCAM-1, and SCF. Subsequently, stem cells are released from the bone marrow into the peripheral blood. The released stem cells can be collected and used in autologous or allogeneic transplantation. To identify better conditions for stem cell mobilization in the treatment of acute and chronic ischemic diseases, several preclinical and clinical studies have been conducted over the past decade on various mobilizing agents. In this paper, we are going to review methods that induce mobilization of stem cells from the bone marrow and introduce the application of stem cell mobilization to therapy of ischemic diseases.

참고문헌 (Reference)

1 Heo SC, "WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells" 32 : 779-790, 2014

2 Flanagan JG, "Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant" 64 : 1025-1035, 1991

3 Wardlaw JM, "Thrombolysis for acute ischaemic stroke" 4 : CD000213-, 2014

4 Mohammadzadeh L, "Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia" 121 : 48-53, 2013

5 Kim BR, "Therapeutic angiogenesis in a murine model of limb ischemia by recombinant periostin and its fasciclin I domain" 1842 : 1324-1332, 2014

6 Read MA, "The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression" 2 : 493-506, 1995

7 Schneider A, "The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis" 115 : 2083-2098, 2005

8 Aiuti A, "The chemokine SDF-1 is a chemoattractant for human CD34 ? hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 ? progenitors to peripheral blood" 185 : 111-120, 1997

9 Girbl T, "The CXCR4 and adhesion molecule expression of CD34 ? hematopoietic cells mobilized by ‘‘on-demand’’ addition of plerixafor to granulocyte-colony-stimulating factor" 54 : 2325-2335, 2014

10 De Clercq E, "The AMD3100 story : the path to the discovery of a stem cell mobilizer(Mozobil)" 77 : 1655-1664, 2009

11 Brannan CI, "Steel- Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains" 88 : 4671-4674, 1991

12 Yang Woo Kwon, "Role of CXCR2 in the Ac‐PGP‐Induced Mobilization of Circulating Angiogenic Cells and its Therapeutic Implications" Wiley 4 : 5-, 2018

13 Dailey T, "Regeneration of neuronal cells following cerebral injury" 32 : 54-61, 2013

14 Dipersio JF, "Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma" 113 : 5720-5726, 2009

15 Reinecke H, "Peripheral arterial disease and critical limb ischaemia : still poor outcomes and lack of guideline adherence" 36 : 932-938, 2015

16 Hira VVV, "Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches" 1868 : 183-198, 2017

17 Wojakowski W, "Mobilization of stem and progenitor cells in cardiovascular diseases" 26 : 23-33, 2012

18 Liles WC, "Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist" 102 : 2728-2730, 2003

19 Miyazawa K, "Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form" 85 : 641-649, 1995

20 Greenbaum AM, "Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization" 25 : 211-217, 2011

21 Kiel MJ, "Maintaining hematopoietic stem cells in the vascular niche" 25 : 862-864, 2006

22 Ratajczak MZ, "Innate immunity as orchestrator of stem cell mobilization" 24 : 1667-1675, 2010

23 Ruscher K, "Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke" 33 : 1225-1234, 2013

24 Tsou LK, "Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology" 38 : 1188-1234, 2018

25 England TJ, "Granulocyte-colony stimulating factor(GCSF)for stroke : an individual patient data meta-analysis" 6 : 36567-, 2016

26 Ripa RS, "Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease" 59 : B4411-, 2012

27 Shyu WC, "Granulocyte colony-stimulating factor for acute ischemic stroke : a randomized controlled trial" 174 : 927-933, 2006

28 Shyu W-C, "Granulocyte colony-stimulating factor for acute ischemic stroke : a randomized controlled trial" 174 : 927-933, 2006

29 Demetri GD, "Granulocyte colony-stimulating factor and its receptor" 78 : 2791-2808, 1991

30 Borlongan CV, "Granulocyte colony-stimulating factor" 175 : 1096-, 2006

31 Moazzami K, "Granulocyte colony stimulating factor therapy for acute myocardial infarction" 4 : 5-, 2013

32 Fischmeister G, "G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells(PBPC)and leukocytes in healthy volunteers : comparison of efficacy and tolerability" 78 : 117-123, 1999

33 Takano H, "G-CSF therapy for acute myocardial infarction" 28 : 512-517, 2007

34 Gibson CL, "G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice" 25 : 431-439, 2005

35 Heo SC, "Formyl peptide receptor 2 Is involved in cardiac repair after myocardial infarction through mobilization of circulating angiogenic cells" 35 : 654-665, 2017

36 Gale RP, "First use of myeloid colony-stimulating factors in humans" 48 : 1358-, 2013

37 Roger VL, "Executive summary : heart disease and stroke statistics—2012 update : a report from the American Heart Association" 125 : 188-197, 2012

38 Spinetti G, "Enhancing stem cell mobility: new hope for treatment of cardiovascular complications in patients with diabetes?" 64 : 2704-2707, 2015

39 Hristov M, "Endothelial progenitor cells : mobilization, differentiation, and homing" 23 : 1185-1189, 2003

40 Ding L, "Endothelial and perivascular cells maintain haematopoietic stem cells" 481 : 457-462, 2012

41 Mao L, "Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/ SDF-1 axis and improve outcome after stroke" 20 : 460-468, 2014

42 Mcgrath KE, "Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4" 213 : 442-456, 1999

43 Deng Z, "Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction" 113 : 92-96, 2006

44 Fadini GP, "Diabetes limits stem cell mobilization following G-CSF but not plerixafor" 64 : 2969-2977, 2015

45 Acar M, "Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal" 526 : 126-130, 2015

46 Bregni M, "Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy" 14 : 628-635, 1996

47 Tay J, "Cellular players of hematopoietic stem cell mobilization in the bone marrow niche" 105 : 129-140, 2017

48 Kucia M, "Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction" 95 : 1191-1199, 2004

49 Compagna R, "Cell therapy in patients with critical limb ischemia" 2015 : 931420-, 2015

50 Wojakowski W, "Cardiomyocyte differentiation of bone marrow-derived Oct-4 ? CXCR4 ? SSEA-1 ? very small embryonic-like stem cells" 37 : 237-247, 2010

51 Nocka K, "Candidate ligand for the c-kit transmembrane kinase receptor : KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors" 9 : 3287-3294, 1990

52 Huang J, "CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice" 44 : 190-197, 2013

53 Nagasawa T, "CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4" 92 : 433-439, 2014

54 Ghobadi A, "Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis, place" 124 : 2752-, 2014

55 Borlongan CV, "Bone marrow stem cell mobilization in stroke: a ‘bonehead’ may be good after all!" 25 : 1674-1686, 2011

56 Winkler IG, "Bone marrow macrophages maintain hematopoietic stem cell(HSC)niches and their depletion mobilizes HSCs" 116 : 4815-4828, 2010

57 Anderlini P, "Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals : recent findings and current challenges" 111 : 1767-1772, 2008

58 Anderlini P, "Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals" 88 : 2819-2825, 1996

59 Ramirez P, "BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells" 114 : 1340-1343, 2009

60 Hopman RK, "Advances in stem cell mobilization" 28 : 31-40, 2014

61 Crane GM, "Adult haematopoietic stem cell niches" 17 : 573-, 2017

62 Anderson JL, "Acute myocardial infarction" 376 : 2053-2064, 2017

63 Dale DC, "A systematic literature review of the efficacy, effectiveness, and safety of filgrastim" 26 : 7-20, 2018

64 Shpall EJ, "A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients" 93 : 2491-2501, 1999

65 Kucia M, "A population of very small embryoniclike(VSEL)CXCR4(?)SSEA-1(?)Oct-4 ? stem cells identified in adult bone marrow" 20 : 857-869, 2006